Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities

MLA

Jiewen Wang, et al. “Novel Bispecific Nanobody Mitigates Experimental Intestinal Inflammation in Mice by Targeting TNF‐α and IL‐23p19 Bioactivities.” Clinical and Translational Medicine, vol. 14, no. 3, Mar. 2024. EBSCOhost, https://doi.org/10.1002/ctm2.1636.

APA

Jiewen Wang, Guangbo Kang, Huiying Lu, Ario deMarco, Haibin Yuan, Zelin Feng, Mengxue Gao, Xiaoli Wang, Huahong Wang, Xiaolan Zhang, Yuli Wang, Miao Zhang, Ping Wang, Yuanhang Feng, Zhanju Liu, Xiaocang Cao, & He Huang. (2024). Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF‐α and IL‐23p19 bioactivities. Clinical and Translational Medicine, 14(3). https://doi.org/10.1002/ctm2.1636

Chicago

Jiewen Wang, Guangbo Kang, Huiying Lu, Ario deMarco, Haibin Yuan, Zelin Feng, Mengxue Gao, et al. 2024. “Novel Bispecific Nanobody Mitigates Experimental Intestinal Inflammation in Mice by Targeting TNF‐α and IL‐23p19 Bioactivities.” Clinical and Translational Medicine 14 (3). doi:10.1002/ctm2.1636.